Equal-WT
WhaleScore 2.0
?
Altium Capital Management is based out of New York. Their last reported 13F filing for Q3 2024 included $339,708,332 in managed 13F securities
and a top 10 holdings concentration of 47.34%. Altium Capital Management's largest holding is Vera Therapeutics Inc with shares held of 684,000. Whalewisdom has at least 18 13F filings, and 167 13G filings

2024-09-30
Top Buys (13F)
Name | % Change |
---|---|
EW Edwards Lifesciences | 4.31% |
GKOS Glaukos Corporation | 2.95% |
MMSI Merit Medical System | 2.47% |
PCVX Vaxcyte, Inc | 2.42% |
ARWR Arrowhead Pharmaceut | 2.02% |

2024-09-30
Top Sells (13F)
Name | % Change |
---|---|
ALIM Alimera Sciences, In | 4.88% |
ARGX Argenx SE ADS ADR | 4.04% |
SKYE Skye Bioscience Inc | 2.9% |
ASND Ascendis Pharma A/S | 2.78% |
INSM Insmed Inc | 2.4% |

2024-09-30
13F Holdings Summary
Name | $ Change |
---|---|
VERA Vera Therapeutics In | 8.9% |
ADMA ADMA Biologics Inc | 8% |
SRPT Sarepta Therapeutics | 6.25% |
EW Edwards Lifesciences | 4.31% |
XENE Xenon Pharmaceutical | 4.18% |

2024-09-30
13F Activity
Market Value | $340m, Prior: $245m |
Inflows (Outflows) as % of Total MV | +16.9558% |
New Purchases | 32 stocks |
Added To | 8 stocks |
Sold out of | 21 stocks |
Reduced holdings in | 12 stocks |
Top 10 Holdings % | 47.34% |
Turnover %[1] | 53% |
Turnover Alt %[2] | 17.35% |
Time Held Top 20 | 2 quarters |
Time Held Top 10 | 1.2 quarters |
Time Held All | 3.35 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2024-09-30
13F Sector Allocation Over Time
limited to past 4 quarters. Subscribe to see all available data

2024-09-30
Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2024-09-30